239 related articles for article (PubMed ID: 18688028)
1. An antimetastatic role for decorin in breast cancer.
Goldoni S; Seidler DG; Heath J; Fassan M; Baffa R; Thakur ML; Owens RT; McQuillan DJ; Iozzo RV
Am J Pathol; 2008 Sep; 173(3):844-55. PubMed ID: 18688028
[TBL] [Abstract][Full Text] [Related]
2. An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells.
Santra M; Eichstetter I; Iozzo RV
J Biol Chem; 2000 Nov; 275(45):35153-61. PubMed ID: 10942781
[TBL] [Abstract][Full Text] [Related]
3. Decorin prevents metastatic spreading of breast cancer.
Reed CC; Waterhouse A; Kirby S; Kay P; Owens RT; McQuillan DJ; Iozzo RV
Oncogene; 2005 Feb; 24(6):1104-10. PubMed ID: 15690056
[TBL] [Abstract][Full Text] [Related]
4. Decorin transfection induces proteomic and phenotypic modulation in breast cancer cells 8701-BC.
Pucci-Minafra I; Cancemi P; Di Cara G; Minafra L; Feo S; Forlino A; Tira ME; Tenni R; Martini D; Ruggeri A; Minafra S
Connect Tissue Res; 2008; 49(1):30-41. PubMed ID: 18293176
[TBL] [Abstract][Full Text] [Related]
5. Synergy of epidermal growth factor receptor kinase inhibitor AG1478 and ErbB2 kinase inhibitor AG879 in human colon carcinoma cells is associated with induction of apoptosis.
Zhou Y; Brattain MG
Cancer Res; 2005 Jul; 65(13):5848-56. PubMed ID: 15994962
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL
Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413
[TBL] [Abstract][Full Text] [Related]
7. Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation.
Seidler DG; Goldoni S; Agnew C; Cardi C; Thakur ML; Owens RT; McQuillan DJ; Iozzo RV
J Biol Chem; 2006 Sep; 281(36):26408-18. PubMed ID: 16835231
[TBL] [Abstract][Full Text] [Related]
8. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.
Zhou Y; Li S; Hu YP; Wang J; Hauser J; Conway AN; Vinci MA; Humphrey L; Zborowska E; Willson JK; Brattain MG
Cancer Res; 2006 Jan; 66(1):404-11. PubMed ID: 16397255
[TBL] [Abstract][Full Text] [Related]
9. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
[TBL] [Abstract][Full Text] [Related]
10. [The action of decorin in anti-fibrosis and anti-cancer].
Ma W; Tan Y; Cai S; Chen H; Du J; Cai S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):222-5. PubMed ID: 17333927
[TBL] [Abstract][Full Text] [Related]
11. Decorin suppresses bone metastasis in a breast cancer cell line.
Araki K; Wakabayashi H; Shintani K; Morikawa J; Matsumine A; Kusuzaki K; Sudo A; Uchida A
Oncology; 2009; 77(2):92-9. PubMed ID: 19590249
[TBL] [Abstract][Full Text] [Related]
12. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract][Full Text] [Related]
13. Decorin-mediated inhibition of proliferation and migration of the human trophoblast via different tyrosine kinase receptors.
Iacob D; Cai J; Tsonis M; Babwah A; Chakraborty C; Bhattacharjee RN; Lala PK
Endocrinology; 2008 Dec; 149(12):6187-97. PubMed ID: 18703624
[TBL] [Abstract][Full Text] [Related]
14. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases.
Santra M; Mann DM; Mercer EW; Skorski T; Calabretta B; Iozzo RV
J Clin Invest; 1997 Jul; 100(1):149-57. PubMed ID: 9202067
[TBL] [Abstract][Full Text] [Related]
15. Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells.
Lee S; Yang W; Lan KH; Sellappan S; Klos K; Hortobagyi G; Hung MC; Yu D
Cancer Res; 2002 Oct; 62(20):5703-10. PubMed ID: 12384528
[TBL] [Abstract][Full Text] [Related]
16. Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model.
Buraschi S; Neill T; Owens RT; Iniguez LA; Purkins G; Vadigepalli R; Evans B; Schaefer L; Peiper SC; Wang ZX; Iozzo RV
PLoS One; 2012; 7(9):e45559. PubMed ID: 23029096
[TBL] [Abstract][Full Text] [Related]
17. Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo.
Csordás G; Santra M; Reed CC; Eichstetter I; McQuillan DJ; Gross D; Nugent MA; Hajnóczky G; Iozzo RV
J Biol Chem; 2000 Oct; 275(42):32879-87. PubMed ID: 10913155
[TBL] [Abstract][Full Text] [Related]
18. Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cells.
Lee H; Saini N; Howard EW; Parris AB; Ma Z; Zhao Q; Zhao M; Liu B; Edgerton SM; Thor AD; Yang X
Sci Rep; 2018 May; 8(1):6829. PubMed ID: 29717218
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts.
Zhang Z; Li XJ; Liu Y; Zhang X; Li YY; Xu WS
Burns; 2007 Aug; 33(5):634-41. PubMed ID: 17374457
[TBL] [Abstract][Full Text] [Related]
20. Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs.
Goldoni S; Iozzo RV
Int J Cancer; 2008 Dec; 123(11):2473-9. PubMed ID: 18798267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
